Valley Grande Institute’s expansion to Raymondville brings new vocational medical educational programs

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Valley Grande Institute’s expansion to Raymondville is now bringing new vocational medical educational programs to Willacy County, beginning with a Medical Clinical Healthcare Technician Program which started in July of 2015. We formally invite you to our:

VGI Raymondville Campus Grand Opening & Ribbon Cutting When: Monday, October 5, 2015 -­‐  10:30 am

Where: EDC Building at 700 FM 3168, Suite #4, Raymondville Texas, 78580

- Advertisement -

Expansion Details:

Valley Grande Institute for Academic Studies, in partnership with the City of Raymondville and the Raymondville Economic Development Council, have expanded to bring VGI’s high-­‐quality vocational medical education to downtown Raymondville at a new campus as of July 2015.

Classes began with a 9-­‐month Medical Clinical Healthcare Technician program at Valley Grande Institute’s new Raymondville campus from 9am to 3pm, Monday through Thursday. VGI students and alumni receive immediate job placement services and get hands-­‐on training and experience in professional communication and interview skills. In as little as 9 months, a student with a high school (or GED) education can begin a professional career with high demand and opportunities for advancement.

Individual attention, tutoring, and test preparation tools are provided to VGI students to help them succeed in a supportive learning environment focused on skill mastery and job placement. Willacy County residents interested in starting a career through Valley Grande Institute  may  visit www.vgi.edu, find us on social media at #vgi4life, or ask  for  educational  opportunities  in Raymondville at (956) 205-­‐1633 and speak to one of VGI’s Admissions Representatives.

- Advertisement -

About Valley Grande Institute

Valley Grande Institute for Academic Studies, established in 1992, is a non-­‐profit (501c3) healthcare school that serves the Rio Grande Valley’s need for professional education. VGI graduates are supported every step of their journey from student learners to employed healthcare professionals.

Valley Grande Institute Raymondville campus is approved by the Texas  Workforce  Commission Career Schools and Colleges, to award students with certificates in programs such as Medical Clinical Healthcare Technician. For more information on our Raymondville, or Weslaco campus, visit www.vgi.edu or call (956)205-­‐1633.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -